The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Buck, Kerstin
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. [electronic resource] - Synapse (New York, N.Y.) Feb 2010 - 117-26 p. digital
Publication Type: Journal Article
1098-2396
10.1002/syn.20709 doi
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists--pharmacokinetics
Adrenergic beta-Antagonists--pharmacology
Animals
Antiparkinson Agents--adverse effects
Brain--drug effects
Cerebrospinal Fluid--metabolism
Disease Models, Animal
Dyskinesia, Drug-Induced--drug therapy
Idazoxan--pharmacology
Levodopa--adverse effects
Male
Motor Activity--drug effects
Oxidopamine
Parkinsonian Disorders--chemically induced
Plasma--metabolism
Propranolol--pharmacology
Random Allocation
Rats
Rats, Wistar
Receptors, Adrenergic, alpha-1--metabolism
Tetralones--pharmacokinetics
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. [electronic resource] - Synapse (New York, N.Y.) Feb 2010 - 117-26 p. digital
Publication Type: Journal Article
1098-2396
10.1002/syn.20709 doi
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists--pharmacokinetics
Adrenergic beta-Antagonists--pharmacology
Animals
Antiparkinson Agents--adverse effects
Brain--drug effects
Cerebrospinal Fluid--metabolism
Disease Models, Animal
Dyskinesia, Drug-Induced--drug therapy
Idazoxan--pharmacology
Levodopa--adverse effects
Male
Motor Activity--drug effects
Oxidopamine
Parkinsonian Disorders--chemically induced
Plasma--metabolism
Propranolol--pharmacology
Random Allocation
Rats
Rats, Wistar
Receptors, Adrenergic, alpha-1--metabolism
Tetralones--pharmacokinetics